CD24 and cancer: Roychoudhury et al. (2018) demonstrated that miR-146a confers stemness via suppression of CD24. Mechanistic analysis revealed that higher CD24 levels inhibit AKT phosphorylation leading to degradation of β-catenin, an important factor for cancer stemness (Roychoudhury et al., 2018).